INIS
rats
100%
patients
92%
drugs
89%
comparative evaluations
64%
doses
62%
learning
54%
evaluation
52%
control
44%
pharmacology
41%
india
40%
hospitals
34%
levels
27%
males
27%
hypertension
26%
mice
25%
data
25%
teaching
24%
toxicity
24%
ulcers
23%
animals
22%
diseases
18%
performance
17%
assessments
17%
reviews
16%
safety
16%
risks
16%
blood
16%
diabetes mellitus
15%
diuretics
15%
lectures
15%
streptozotocin
15%
malaria
15%
titration
15%
nervous system diseases
15%
liver
14%
cholesterol
14%
intake
14%
reduction
13%
gum acacia
12%
glucose
12%
clinical trials
12%
inflammation
12%
fruits
11%
feedback
11%
lipids
11%
administration
11%
cancer
11%
creatinine
10%
pregnancy
10%
fats
10%
Pharmacology, Toxicology and Pharmaceutical Science
Drug
39%
Wistar Rat
32%
Diabetes Mellitus
26%
Toxicity
16%
Antidiabetic Agent
15%
foot ulcer, diabetic
15%
Alzheimer Disease
15%
Resveratrol
15%
Rat
14%
Creatinine
12%
Malaria
12%
Hypertension
12%
Adverse Event
10%
Ethanol
10%
Donepezil
8%
Molecular Marker
7%
Vanillin
7%
Tocilizumab
7%
Lycium
7%
Syzygium cumini
7%
Costus
7%
Non-Steroidal Anti-Inflammatory Drug
7%
Prevalence
7%
Tribulus terrestris
7%
Camellia Sinensis
7%
Chemotherapy
7%
Chloroquine
7%
Liver Injury
7%
Lipid
7%
Thioacetamide
7%
Cardiovascular Disease
7%
Neuroprotective Agent
7%
Oropharynx Cancer
7%
Streptozotocin
7%
Behavioral Toxicity
7%
Alocasia
7%
Diuretic Activity
7%
Pancreatitis
7%
Bacopa monnieri
7%
Alpinia galanga
7%
Hyperlipidemia
7%
Non Communicable Disease
7%
Antihypertensive Agent
7%
Modafinil
7%
Colchicine
7%
Hydrochlorothiazide
6%
Toxic Hepatitis
6%
Diseases
6%
Glibenclamide
6%
Observational Study
5%
Medicine and Dentistry
Patient
39%
Diabetes Mellitus
23%
Diabetic Foot Ulcer
15%
Learning
15%
Student
12%
Therapeutic Procedure
11%
Medical Student
10%
Clinical Trial
10%
Comprehension
9%
Male
9%
Prevalence
8%
Tertiary Care
8%
Hospital
8%
Rural Population
7%
Amaurosis
7%
Pyridoxine
7%
Development
7%
Pancreatitis
7%
Assessment
7%
Health Literacy
7%
Diuretic Activity
7%
Geriatrics
7%
Non Communicable Disease
7%
Radiation Therapy
7%
Tribulus terrestris
7%
Liver Toxicity
7%
Quality of Life
7%
Evaluation Study
7%
Antidiabetic Activity
7%
Adverse Event
7%
Examination
7%
Streptozocin
7%
Clinical Reasoning
7%
Experience
7%
Astrocyte
7%
Resveratrol
7%
Alzheimer's Disease
7%
Cells
7%
Colchicine
7%
Donepezil
7%
Hypertension
7%
Inpatient
6%
Placebo
5%
Follow up
5%
Neoplasm
5%